Variant report

Variant	nsv960060
Chromosome Location	chr17:15637240-15642135
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:7)
CpG islands
(count:0)
Chromatin interactive
region (count:0)
LncRNA
region (count:10)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:7 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr17:15641806-15641845	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr17:15640241-15640287	Pancreas_OC	pancreas:	n/a	n/a
3	ESR1	chr17:15636852-15637283	ECC-1	luminal epithelium:	n/a	n/a
4	MYC	chr17:15640329-15640454	H1-hESC	embryonic stem cell:	n/a	n/a
5	MYC	chr17:15637244-15637339	H1-hESC	embryonic stem cell:	n/a	n/a
6	MYC	chr17:15639890-15640001	H1-hESC	embryonic stem cell:	n/a	n/a
7	POLR2A	chr17:15637285-15637307	MCF-7	breast:	n/a	n/a

No data

(count:10 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF286A-7	chr17:15638018-15638177	NONHSAT145856
2	lnc-ZNF286A-7	chr17:15638047-15638347	NONHSAT145858
3	lnc-ZNF286A-7	chr17:15637028-15637251	NONHSAT145856
4	lnc-ZNF286A-7	chr17:15637356-15637402	NONHSAT145856
5	lnc-TRIM16-1	chr17:15641817-15642103	ENSG00000233002.2
6	lnc-TRIM16-1	chr17:15639034-15639149	ENSG00000233002.2
7	lnc-ZNF286A-7	chr17:15637159-15637402	NONHSAT145859
8	lnc-TRIM16-1	chr17:15639776-15639863	ENSG00000233002.2
9	lnc-TRIM16-1	chr17:15638337-15638689	ENSG00000233002.2
10	lnc-ZNF286A-7	chr17:15638018-15638351	NONHSAT145859

No data

Variant related genes	Relation type
TBC1D26	TF binding region

Extended variants
information (count: 234 )
Associated
traits (count: 126 )

Variant overlapped rSNPs/rCNVs (count:234 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149913507	chr17:15637275-15637276	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs144935648	chr17:15637278-15637279	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs370384699	chr17:15637279-15637280	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs149045128	chr17:15637307-15637308	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs142056135	chr17:15637357-15637358	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs530185542	chr17:15637457-15637458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs374781821	chr17:15637458-15637459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs543714627	chr17:15637476-15637477	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs563603472	chr17:15637504-15637505	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs532559332	chr17:15637510-15637511	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs552265218	chr17:15637553-15637554	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs566196916	chr17:15637561-15637562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs368627839	chr17:15637651-15637652	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs115911222	chr17:15637687-15637688	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs116228089	chr17:15637704-15637705	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs541269517	chr17:15637732-15637733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs2529988	chr17:15637760-15637761	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
18	rs187428375	chr17:15637764-15637765	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs11653200	chr17:15637844-15637845	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs151223787	chr17:15637855-15637856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs140368404	chr17:15637882-15637883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs568727835	chr17:15637890-15637891	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs113428644	chr17:15637932-15637933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs553708809	chr17:15637943-15637944	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs575009876	chr17:15637944-15637945	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs192123804	chr17:15637950-15637951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs554202361	chr17:15637953-15637954	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs574707300	chr17:15637999-15638000	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs58227457	chr17:15638049-15638050	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
30	rs182959471	chr17:15638067-15638068	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
31	rs577448999	chr17:15638074-15638075	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
32	rs573034189	chr17:15638101-15638102	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
33	rs2529987	chr17:15638121-15638122	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs369143204	chr17:15638159-15638160	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
35	rs140993741	chr17:15638172-15638173	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
36	rs187635779	chr17:15638216-15638217	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs150227110	chr17:15638227-15638228	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
38	rs548711388	chr17:15638242-15638243	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
39	rs562132042	chr17:15638265-15638266	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
40	rs529937177	chr17:15638272-15638273	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
41	rs2529986	chr17:15638273-15638274	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
42	rs549981884	chr17:15638322-15638323	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
43	rs569967489	chr17:15638330-15638331	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs538548382	chr17:15638334-15638335	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
45	rs7217168	chr17:15638362-15638363	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs138542671	chr17:15638363-15638364	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs190114097	chr17:15638365-15638366	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs534576271	chr17:15638409-15638410	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs554265654	chr17:15638440-15638441	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs574170431	chr17:15638527-15638528	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:126)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD

Chromatin state (count:9 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15634000-15639200	Weak transcription	Fetal Stomach	stomach
2	chr17:15636600-15637400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr17:15637000-15638800	Enhancers	Placenta	Placenta
4	chr17:15637400-15647400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr17:15638800-15639200	Weak transcription	Placenta	Placenta
6	chr17:15639200-15639400	Enhancers	Placenta	Placenta
7	chr17:15639400-15646400	Weak transcription	Placenta	Placenta
8	chr17:15641800-15642000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr17:15642000-15644200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links